For several years, the implementation of Serialization and Track & Trace was driven by regulatory bodies to increase patient safety and manufacturers invested millions to enhance their systems. Despite regulatory driven projects, more and more market-demands are upcoming to cover the needs of our customers. For instance, the EU-FMD legislation leads to a high decommissioning workload for hospital pharmacies.

Fresenius Kabi started a pilot-project together with four customers to establish a web-portal solution based on GS1-standards. The system enables our customers to receive aggregation information and to perform an effective mass-decommissioning. However, despite market demands, manufactures will increasingly focus on process efficiency in production and supply chain.

What to expect?

The looming deadline of 01 January 2020 for complying with Russia’s Federal Law No. 425-FZ that dictates the requirements of drug serialization that manufacturers must meet. Meeting the challenge requires a different approach to the technology solutions that stakeholders implemented for EU and other countries’ regulations. 

During this session, learn about the ongoing and prospective terms of the operation of MDLP, Crypto sub-system and billing (code payment). Gain insight into expected changes to Governmental Decrees 1556. 
There will be a review of the final architecture and logical schemes of the complete MDLP operation. In addition, the presentation will cover issues of implementation timing, emission recorders application, codes expiration times and more.

What to expect?

A short overview will be given of some of the highlighted new features of Movilitas.Cloud. Focus will be given to the Russian reporting capabilities (MDLP), Manufacturing applications for other industries that require serialization, footwear, light, etc. and using our Movilitas Mobile for VRS in the USA in combination with SAP ICH. 

What to expect?